Learn more

ONYVAX LTD

Overview
  • Total Patents
    66
About

ONYVAX LTD has a total of 66 patent applications. Its first patent ever was published in 1998. It filed its patents most often in United Kingdom, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals and biotechnology are NORDIC VACCINE TECHNOLOGY AS, HENDERSON MORLEY PLC and NOVARX.

Patent filings per year

Chart showing ONYVAX LTDs patent filings per year from 1900 to 2020

Focus industries

# Industry
#1 Pharmaceuticals
#2 Biotechnology

Top inventors

# Name Total Patents
#1 Dalgleish Angus George 31
#2 Walker Anthony Ian 29
#3 Sutton Andrew Derek 25
#4 Smith Peter Michael 25
#5 Sutton Andrew 14
#6 Thraves Peter 12
#7 Chana Haj 10
#8 Stevenson Darren 10
#9 Smith Peter 9
#10 Whelan Michael 3

Latest patents

Publication Filing date Title
US2005058668A1 Human prostate cell lines in cancer treatment
GB0204022D0 Nucleic acid quantification
WO0175073A2 Prostate cell lines and their use
GB0024237D0 New prostate cell lines
AU4935600A New vaccine formulations - 2
AU4935700A New vaccine formulations-3
GB0008029D0 New vaccine formulations
GB0008032D0 New prostate cell lines
NZ527763A Allogeneic immunotherapeutic agent comprising three human prostate tumour cell lines derived from three different primary tumours useful in treating prostate cancer
GB9911825D0 New vaccine formulations
GB9911823D0 New vaccine formulations
GB9911824D0 New vaccine formulations
GB9827102D0 New cancer treatments
GB9827103D0 New cancer treatments
GB9827104D0 New cancer treatments